Literature DB >> 11076879

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

R C Spiller1, D Jenkins, J P Thornley, J M Hebden, T Wright, M Skinner, K R Neal.   

Abstract

BACKGROUND AND AIMS: Post-dysenteric irritable bowel syndrome (PD-IBS) develops in up to 25% of patients following Campylobacter enteritis. Our aim was to define the pathological basis of this subgroup of IBS.
METHODS: Twenty one patients (group 1) underwent serial rectal biopsy and gut permeability testing following acute Campylobacter enteritis as did 10 PD-IBS patients (group 2) and 12 asymptomatic controls.
RESULTS: In group 1, enteroendocrine cell (EC) numbers were markedly increased initially and at six and 12 weeks (p<0.001) compared with controls. Gut permeability, as assessed by the lactulose/mannitol ratio, was significantly elevated, initially and at 12 weeks (p<0.005). CD3, CD4, and CD8 lymphocyte counts in the lamina propria and intraepithelial lymphocytes (IEL) were significantly increased initially compared with controls. At visit 1, EC numbers were positively correlated with CD3 counts (r=0.6, p=0.01). At one year, seven subjects (five with persistent loose stools) had rectal biopsies which showed significantly elevated EC, CD3, and IEL counts. In group 2, EC and IEL counts were significantly increased compared with controls (p<0.001), as was gut permeability (p<0.01).
CONCLUSION: Increased EC, T lymphocytes, and gut permeability are acute changes following Campylobacter enteritis which can persist for more than a year and may contribute to PD-IBS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076879      PMCID: PMC1728147          DOI: 10.1136/gut.47.6.804

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  43 in total

1.  Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative.

Authors:  D Jenkins; M Balsitis; S Gallivan; M F Dixon; H M Gilmour; N A Shepherd; A Theodossi; G T Williams
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

2.  Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon.

Authors:  K Kyösola; O Penttilä; M Salaspuro
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

3.  Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy.

Authors:  J Calam; M A Ghatei; J Domin; T E Adrian; M Myszor; S Gupta; C Tait; S R Bloom
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

4.  Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis.

Authors:  C M Fernandez-Prada; D L Hoover; B D Tall; M M Venkatesan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

Review 5.  5-Hydroxytryptamine and functional bowel disorders.

Authors:  G J Sanger
Journal:  Neurogastroenterol Motil       Date:  1996-12       Impact factor: 3.598

6.  Peptide YY augments postprandial small intestinal absorption in the conscious dog.

Authors:  A J Bilchik; O J Hines; M J Zinner; T E Adrian; J J Berger; S W Ashley; D W McFadden
Journal:  Am J Surg       Date:  1994-06       Impact factor: 2.565

7.  Terminal ileal mucosal mast cells in irritable bowel syndrome.

Authors:  A P Weston; W L Biddle; P S Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

8.  Prognosis in the irritable bowel syndrome: a 5-year prospective study.

Authors:  R F Harvey; E C Mauad; A M Brown
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

9.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

10.  Enteropathy of coeliac disease in adults: increased number of enterochromaffin cells the duodenal mucosa.

Authors:  K Sjölund; J Alumets; N O Berg; R Håkanson; F Sundler
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

View more
  307 in total

1.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 2.  Role of nerves in enteric infection.

Authors:  R C Spiller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

3.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

4.  Vesicular glutamate transporter-3 contributes to visceral hyperalgesia induced by Trichinella spiralis infection in rats.

Authors:  Chang-Qing Yang; Yan-Yu Wei; Yu-Xin Leng; Chan-Juan Zhong; Yong-Shen Zhang; You Wan; Li-Ping Duan
Journal:  Dig Dis Sci       Date:  2011-12-09       Impact factor: 3.199

Review 5.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

6.  Keeping neuroendocrine cells in check: roles for TGFbeta, Smads, and menin?

Authors:  G J Dockray
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

7.  Irritable Bowel Syndrome: Bacterial Overgrowth--What's Known and What to Do.

Authors:  Mark Pimentel; Sheila Lezcano
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

8.  Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

Authors:  Ji Yong Ahn; Kyung Hun Lee; Chang Hwan Choi; Ju Wan Kim; Hyun Woong Lee; Jeong Wook Kim; Mi Kyung Kim; Gui Young Kwon; Seungbong Han; Seong-Eun Kim; Sung Min Kim; Sae Kyung Chang
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

Review 9.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

10.  Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.

Authors:  Arseima Y Del Valle-Pinero; Hendrick E Van Deventer; Nicolaas H Fourie; Angela C Martino; Nayan S Patel; Alan T Remaley; Wendy A Henderson
Journal:  Clin Chim Acta       Date:  2013-01-14       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.